Loading
A phase 1 trial of Tozuleristide run by Blaze Bioscience Inc., completed.
Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery is a phase 1 interventional study registered as NCT02234297 by Blaze Bioscience Inc., with 17 participants enrolled, started 2014-10. Conditions recorded: Glioma. Interventions recorded: BLZ-100.
Shares Tozuleristide, Blaze Bioscience, Brain and spinal cord tumours (all types) and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience, Brain and spinal cord tumours (all types) and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/